Executives On The Move: Development Hires At BiomX And CytomX, Revance Chooses a CEO

 
• By Regina Paleski

Two new chief development officers: former Teva Pharma exec moves to microbiome-based therapeutics firm BiomX; and BioGene CMO makes a change to oncology biopharma CytomX. At Revance Therapeutics, a developer of therapeutic neuromodulators, a CEO is chosen.

More from Executives On The Move

More from Leadership